Halozyme Surrenders Most Of Its Pre-Market Gains
January 05, 2017 at 11:59 AM EST
Halozyme Therapeutics, Inc. (NASDAQ: HALO) shares are trading higher by $1.31 at $12.00 in Thursday's session. The issue spiked to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.